Potential role of intensity modulated proton beams in prostate cancer radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 49, Issue 1, 2001, Pages 217-223

  Cella, Laura ^a   Lomax, Antony ^b   Miralbell, Raymond ^a,c  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

^c Hospital Cantonal   (Switzerland)

Author keywords

Conformal radiotherapy; Dose escalation; Intensity modulated radiotherapy; Prostate cancer; Proton therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROTON;

ARTICLE; BLADDER; CANCER CONTROL; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMUR HEAD; HUMAN; INTERMETHOD COMPARISON; MALE; MORBIDITY; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; PROTON RADIATION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RECTUM; STANDARD; TECHNIQUE; TREATMENT PLANNING; VOLUMETRY; X IRRADIATION;

FEMUR HEAD; HUMANS; MALE; PROSTATIC NEOPLASMS; PROTONS; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RECTUM; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER;

EID: 0035169882     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)01368-7     Document Type: Article

References (30)

1. Radical radiation therapy in the management of prostatic adenocarcinoma. The initial prostate specific antigen value as a predictor of treatment outcome
2. Prognostic factors for clinically localized prostate carcinoma. Analysis of 938 patients irradiated in the prostate specific antigen era
3. The effect of dose on local control of prostate cancer
4. Advanced prostate cancer; The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone
5. Late GI and GU complications in the treatment of prostate cancer
6. Potential improvement in the results of irradiation for prostate carcinoma using improved dose distribution
7. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer; A randomised trial
8. Three-dimensional solution of the inverse problem in conformation radiotherapy
9. Optimization of radiation therapy
10. Proton beam therapy
11. Intensity modulation methods for proton radiotherapy
12. Reproducibility of conformal radiation therapy in localized carcinoma of the prostate without rigid immobilization
13. Conformal proton therapy for prostate carcinoma
14. Planning delivery, and quality assurance of intensity modulated radiotherapy using dynamic multileaf collimator; A strategy for large-scale implementation for the treatment of carcinoma of the prostate
15. The exchange of radiotherapy data as part of an electronic patient referral system
16. A 3D treatment planning for conformal proton therapy by spot scanning
17. Complication probability as assessed from dose-volume histograms
18. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations
19. The probability of controlling an inhomogeneously irradiated tumor
20. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
21. Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy
22. Radiotherapy for prostate cancer; Should the seminal vesicles be considered target?
23. Correlation of pretherapy prostate cancer chacteristics with seminal vesicle invasion in radical prostatectomy specimens
24. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy
25. Patient positioning in prostate radiotherapy. Is prone better than supine?
26. A feasability study of automated inverse treatment planning for cancer of the prostate
27. Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma
28. Value of DVH assessments; Can they accurately predict for toxicity?
29. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma